Profile data is unavailable for this security.
About the company
Medmix AG is a Switzerland-based company primarily engaged in manufacturing of healthcare, dental and beauty devices. The Company operates through two reportable segments: Healthcare along with Consumer and Industrial. Healthcare segment includes design and production of high-precision delivery devices and services within drug delivery, surgery and dental markets. Products include injection pens, surgical delivery devices focusing on trauma bone repair and wound healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry. Consumer and Industrial segment consists of design and production of high precision delivery devices within industry business unit, this includes adhesives used in construction, electronics, automotive, aerospace and various industries, and consumer markets such as beauty and other microbrush applications.
- Revenue in CHF (TTM)448.00m
- Net income in CHF6.40m
- Incorporated2021
- Employees2.57k
- Locationmedmix AGc/o Nimbus AGZiegelbrueckstrasse 82, ZiegelbrueckeBAAR 8866SwitzerlandCHE
- Phone+41 556173744
- Websitehttps://www.medmix.swiss/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onward Medical NV | 1.01m | -35.20m | 207.12m | 102.00 | -- | 6.54 | -- | 204.49 | -0.866 | -0.866 | 0.0249 | 0.6209 | 0.0215 | -- | 9.11 | 10,901.96 | -74.86 | -55.03 | -92.84 | -61.19 | 77.16 | -- | -3,475.81 | -39,652.37 | 4.30 | -17.13 | 0.352 | -- | 236.76 | -- | 1.26 | -- | 3.88 | -- |
| Stratec SE | 234.00m | 14.26m | 228.67m | 1.42k | 16.04 | 1.05 | 7.28 | 0.9772 | 1.29 | 1.29 | 21.13 | 19.75 | 0.5825 | 1.32 | 5.65 | 177,177.20 | 3.55 | 6.72 | 4.24 | 7.96 | 29.09 | 28.41 | 6.09 | 9.63 | 1.65 | 6.85 | 0.3552 | 37.35 | -4.73 | 3.76 | 4.24 | 2.35 | -7.49 | -6.51 |
| CellaVision AB | 64.56m | 13.02m | 299.47m | 236.00 | 23.00 | 3.97 | 18.30 | 4.64 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
| Medistim ASA | 54.38m | 11.58m | 329.57m | 154.00 | 28.37 | 9.65 | 23.98 | 6.06 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| IVF Hartmann Holding AG | 159.45m | 19.02m | 331.20m | 309.00 | 17.42 | 2.28 | 13.68 | 2.08 | 7.92 | 7.92 | 66.39 | 60.57 | 0.8964 | 3.28 | 7.88 | 526,221.10 | 10.69 | 7.90 | 12.91 | 9.68 | 55.71 | 54.06 | 11.93 | 9.13 | 3.79 | -- | 0.0042 | 48.54 | 7.33 | 2.85 | 34.02 | 10.78 | -28.94 | 19.92 |
| COLTENE Holding AG | 240.71m | 14.31m | 335.83m | 1.18k | 23.46 | 3.71 | 15.94 | 1.40 | 2.40 | 2.40 | 40.22 | 15.13 | 1.31 | 1.34 | 6.40 | 204,684.50 | 7.80 | 10.59 | 14.26 | 18.43 | 66.11 | 62.19 | 5.95 | 7.64 | 0.7043 | 7.62 | 0.3606 | 85.66 | 3.06 | -1.79 | 71.31 | 0.4306 | -15.45 | 10.76 |
| medmix AG | 448.00m | 6.40m | 388.69m | 2.57k | 62.65 | 0.90 | 6.54 | 0.8676 | 0.1504 | 0.1504 | 10.66 | 10.47 | 0.469 | 3.82 | 6.53 | 174,048.20 | 0.7432 | 1.16 | 0.9112 | 1.42 | 36.14 | 35.53 | 1.58 | 2.43 | 1.11 | 3.29 | 0.4328 | 156.41 | -7.42 | 4.98 | 186.49 | -7.79 | -0.9458 | -- |
| Ion Beam Applications SA | 543.42m | 15.49m | 425.31m | 2.10k | 27.16 | 3.80 | 15.84 | 0.7827 | 0.5677 | 0.5677 | 20.17 | 4.06 | 0.9756 | 2.73 | 3.28 | 281,693.60 | 2.78 | 1.50 | 12.03 | 4.64 | 31.21 | 34.39 | 2.85 | 2.15 | 0.6209 | 7.41 | 0.3631 | 70.81 | 6.75 | 12.01 | 201.57 | 3.99 | 7.69 | 25.86 |
| Revenio Group Oyj | 99.92m | 15.85m | 445.21m | 247.00 | 28.01 | 4.25 | 22.42 | 4.46 | 0.654 | 0.654 | 4.12 | 4.31 | 0.7515 | 3.05 | 7.26 | 444,129.60 | 11.92 | 14.00 | 14.23 | 17.40 | 70.92 | 70.95 | 15.86 | 19.38 | 1.63 | 9.66 | 0.0969 | -- | 5.97 | 12.43 | -5.93 | 5.42 | 22.19 | -- |
| Xvivo Perfusion AB | 69.09m | 2.14m | 482.32m | 198.00 | 225.92 | 2.68 | 59.45 | 6.98 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Advanced Medical Solutions Group plc | 230.18m | 9.53m | 484.10m | 1.50k | 50.61 | 1.81 | 15.24 | 2.10 | 0.0417 | 0.0417 | 1.01 | 1.17 | 0.5758 | 2.09 | 5.57 | 137,690.00 | 2.38 | 5.09 | 2.63 | 5.52 | 52.19 | 55.06 | 4.14 | 11.15 | 1.55 | 3.88 | 0.2428 | 33.47 | 40.66 | 11.64 | -55.35 | -17.81 | 8.36 | 10.90 |
| Lumibird SA | 196.69m | 9.77m | 487.03m | 1.07k | 49.85 | 2.67 | 17.57 | 2.48 | 0.4775 | 0.4775 | 9.61 | 8.90 | 0.5077 | 0.9593 | 4.42 | 202,198.50 | 2.52 | 2.51 | 3.11 | 3.17 | 63.89 | 61.89 | 4.97 | 4.90 | 1.64 | 3.16 | 0.4583 | 0.00 | 1.75 | 13.34 | -20.08 | -8.38 | 15.27 | -- |
| RaySearch Laboratories AB (publ) | 114.35m | 19.38m | 487.32m | 458.00 | 27.98 | 6.47 | 11.05 | 4.26 | 6.65 | 6.65 | 39.25 | 28.74 | 0.6584 | 6.25 | 2.93 | 2,935,074.00 | 11.16 | 5.26 | 16.21 | 7.77 | 92.42 | 91.01 | 16.94 | 9.70 | 1.66 | 64.92 | 0.2861 | 52.38 | 12.77 | 15.58 | 11.93 | -- | 0.2213 | -- |
| Gerresheimer AG | 2.05bn | 21.27m | 507.14m | 13.54k | 23.85 | 0.3972 | 1.99 | 0.2474 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Synektik SA | 151.74m | 29.03m | 547.29m | 203.00 | 18.85 | 9.86 | 16.60 | 3.61 | 15.84 | 12.20 | 82.79 | 30.29 | 1.30 | 6.46 | 5.73 | -- | 24.78 | 20.11 | 45.33 | 32.67 | 36.50 | 31.40 | 19.13 | 13.60 | 1.22 | 111.98 | 0.1114 | -- | 9.16 | 40.29 | 51.58 | 70.02 | 28.82 | -- |
Data as of Mar 03 2026. Currency figures normalised to medmix AG's reporting currency: Swiss Franc CHF
18.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Advisors (UK) Ltd.as of 31 Dec 2024 | 2.03m | 4.91% |
| UBS Asset Management Switzerland AGas of 18 Dec 2025 | 1.25m | 3.03% |
| Fidelity Investments Canada ULCas of 30 Nov 2025 | 1.10m | 2.67% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 926.14k | 2.25% |
| Artisan Partners LPas of 31 Dec 2025 | 512.56k | 1.24% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 399.13k | 0.97% |
| Oddo BHF Asset Management SASas of 30 Jan 2026 | 386.26k | 0.94% |
| Z�rcher Kantonalbank (Investment Management)as of 30 Jan 2026 | 352.11k | 0.85% |
| Baumann & Cie KmGas of 31 Oct 2025 | 300.00k | 0.73% |
| Bellevue Asset Management AGas of 30 Jan 2026 | 272.92k | 0.66% |
More ▼
Data from 31 Oct 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
